A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Running, not enrolling · Phase 3
Conditions studied: Plaque Psoriasis
In brief
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study treatments of TAK-279 and will be treated with TAK-279 if the participants meet the study rules. Participants will be in the study for up to 217 weeks, including up to 35 days for the screening period, 52 weeks (Part A) up to 156 additional weeks (Part B) study treatment and 4 weeks follow up period. During the study, participants will visit their study clinic multiple times.
Key facts
- Study ID
- NCT06550076
- Run by
- Takeda
- People needed
- 2099
- Starts
- 2024-09-04
- Expected to finish
- 2029-08-05
- Last updated by the study team
- 2026-06-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama Hospital - Whitaker Clinic - — Birmingham, Alabama, United States
- Cahaba Dermatology Skin Health Center — Hoover, Alabama, United States
- Medical Dermatology Specialists — Phoenix, Arizona, United States
- Saguaro Dermatology Associates, LLC - Probity - PPDS — Phoenix, Arizona, United States
- Noble Clinical Research — Tucson, Arizona, United States
- Johnson Dermatology Clinic — Fort Smith, Arkansas, United States
- Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
- Zenith Research, Inc. — Beverly Hills, California, United States
- First OC Dermatology Research Inc. — Fountain Valley, California, United States
- Center for Dermatology Clinical Research — Fremont, California, United States
- Long Beach Research Institute — Long Beach, California, United States
- Metropolis Dermatology Downtown LA - Probity - PPDS — Los Angeles, California, United States
- UCLA University of California Los Angeles — Los Angeles, California, United States
- Northridge Clinical Trials — Northridge, California, United States
- UC Davis Dermatology Clinic — Sacramento, California, United States
- TCR Medical Corporation — San Diego, California, United States
- University Clinical Trials — San Diego, California, United States
- Dermatology Institute and Skin Care Center — Santa Monica, California, United States
- UNISON Clinical Trials (Shahram Jacobs md inc.) — Sherman Oaks, California, United States
- Driven Research LLC — Coral Gables, Florida, United States
- Revival Research Corporation - Florida - ClinEdge - PPDS — Doral, Florida, United States
- FXM Clinical Research Ft. Lauderdale, LLC — Fort Lauderdale, Florida, United States
- Direct Helpers Medical Center — Hialeah, Florida, United States
- Florida Academic Centers Research — Miami, Florida, United States
- Total Dermatology — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.